Literature DB >> 9541430

Congenital ectopia lentis. A Danish national survey.

J Fuchs1, T Rosenberg.   

Abstract

PURPOSE: To elucidate demographic and nosologic characteristics of congenital ectopia lentis (ECL) in Denmark.
METHODS: A register of affected persons was established based on information provided from medical records and files in a nation-wide retrospective study, the Danish ECL-study.
RESULTS: Three hundred and ninety-six cases (197 males, 199 females) with ECL were included in the study. By January 1st, 1993, the estimated prevalence rate of ECL was 6.4/100,000. The estimated average point prevalence rate at birth 1976-85 was 0.83/10,000 live born. Only in 69% of the cases (274/396) was a nosologic classification possible, based on preexisting information about familial occurrence, systemic and ocular findings: Marfan syndrome was found in 68.2% of these (187/274), ectopia lentis et pupillae in 21.2%, simple dominant ectopia lentis in 8.0%, homocystinuria in 1.1%, sulfite oxidase deficiency and Weill-Marchesani syndrome in 0.7% each. In the remaining 31% (122/396) a nosologic diagnosis could not be established.
CONCLUSION: The majority of affected persons have congenital ectopia lentis as a manifestation of a systemic disease. It is therefore essential to evaluate ECL patients systemically with a general physical examination, a metabolic screening, and an echocardiography as a minimum, in order to make a nosologic diagnosis and to prevent potentially life-threatening systemic complications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541430     DOI: 10.1034/j.1600-0420.1998.760105.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  14 in total

1.  Alternative diagnoses with ectopia lentis.

Authors:  A Chandra; J A Aragon Martin; A H Child; G Arno; D G Charteris
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

Review 2.  Molecular pathogenesis and management strategies of ectopia lentis.

Authors:  A Chandra; D Charteris
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

3.  [Bilateral corectopia with lenses displaced in opposite directions].

Authors:  C Dietz; S Dimopoulos; K U Bartz-Schmidt; J M Rohrbach
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

4.  Trends and characteristics of congenital ectopia lentis in China.

Authors:  Guang-Ming Jin; Min Fan; Qian-Zhong Cao; Jun-Xiong Lin; Yi-Chi Zhang; Jian-Qiang Lin; Yi-Yao Wang; Charlotte-Aimee Young; Dan-Ying Zheng
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

5.  Outcomes of Scleral-fixated Intraocular-lens in Children with Idiopathic Ectopia Lentis.

Authors:  Abdulaziz I Al Somali; Faisal N Al-Dossari; Khalid E Emara; Ahmed Al Habash
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Oct-Dec

6.  Bilateral posterior crystalline lens dislocations in an otherwise healthy child.

Authors:  Omar A AlShehri; Hashem Almarzouki; Badr A Alharbi; Mohammed Alqahtani; Khaled Allam
Journal:  GMS Ophthalmol Cases       Date:  2017-10-20

7.  What hinders congenital ectopia lentis patients' follow-up visits? A qualitative study.

Authors:  Jianqiang Lin; Ni Gong; Qianzhong Cao; Yijing Zhou; Yitingxue Cai; Guangming Jin; Charlotte Aimee Young; Jing Yang; Yiyao Wang; Danying Zheng
Journal:  BMJ Open       Date:  2020-03-12       Impact factor: 2.692

Review 8.  Zinn's zonule.

Authors:  Steven Bassnett
Journal:  Prog Retin Eye Res       Date:  2020-09-25       Impact factor: 21.198

9.  Clinical Ocular Diagnostic Model of Marfan Syndrome in Patients With Congenital Ectopia Lentis by Pentacam AXL System.

Authors:  Tianhui Chen; Jiahui Chen; Guangming Jin; Min Zhang; Zexu Chen; Danying Zheng; Yongxiang Jiang
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

10.  Mutation survey of candidate genes in 40 Chinese patients with congenital ectopia lentis.

Authors:  Jie Li; Xiaoyun Jia; Shiqiang Li; Shaohua Fang; Xiangming Guo
Journal:  Mol Vis       Date:  2014-07-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.